Lv21
180 积分 2025-09-23 加入
Venetoclax Plus Hypomethylating Agent for 7‐ Versus 14‐ Versus 21‐ Versus 28‐Day Cycles in Newly‐Diagnosed Acute Myeloid Leukemia: ELN and Mayo Genetic Risk–Stratified Analysis in 540 Patients
3小时前
已完结
Cardiac effects of deferasirox in transfusion‐dependent patients with myelodysplastic syndromes: TELESTO study
4个月前
已完结
Allogeneic hematopoietic stem cell transplantation to improve survival in acute myeloid leukemia patients with FLT3 internal tandem duplication
5个月前
已关闭
Data from Multi-center phase I trial of Ivosidenib as Maintenance Treatment following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
5个月前
已关闭
Indirect Treatment Comparison of Oral Versus Injectable Azacitidine as Maintenance Therapy for Acute Myeloid Leukemia
5个月前
已关闭
Indirect Treatment Comparison of Oral Versus Injectable Azacitidine as Maintenance Therapy for Acute Myeloid Leukemia
5个月前
已关闭
How I treat AML relapse after allogeneic HSCT
6个月前
已完结
Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial
6个月前
已完结
Relapse and resistance in acute myeloid leukemia post venetoclax: improving second lines therapy and combinations
6个月前
已完结
T- and T/natural killer-cell lymphomas of the salivary gland: A clinicopathologic, immunohistochemical and molecular study of six cases
9个月前
已完结
Next generation sequencing identifies a pathogenic mutation of WFS1 gene in a Moroccan family with Wolfram syndrome: a case report
Spillover of Azithromycin Mass Drug Administration and Child Survival: A Secondary Analysis of a Cluster-Randomized Clinical Trial
皖公网安备34019202002308
